These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
397 related articles for article (PubMed ID: 25446039)
1. Management and outcome of adults with skin and soft tissue infection caused by methicillin-resistant Staphylococcus aureus in a tertiary hospital in central Taiwan. Teh SH; Chi CY; Lin PC; Ho CM; Chou CH; Tsai CT; Wang JH; Ho MW J Microbiol Immunol Infect; 2015 Oct; 48(5):497-503. PubMed ID: 25446039 [TBL] [Abstract][Full Text] [Related]
2. The role of antimicrobial therapy for treatment of uncomplicated skin and soft tissue infections from community-acquired methicillin-resistant Staphylococcus aureus in children. Teng CS; Lo WT; Wang SR; Tseng MH; Chu ML; Wang CC J Microbiol Immunol Infect; 2009 Aug; 42(4):324-8. PubMed ID: 19949756 [TBL] [Abstract][Full Text] [Related]
3. Changes in prescriptive practices in skin and soft tissue infections associated with the increased occurrence of community acquired methicillin resistant Staphylococcus aureus. Meddles-Torres C; Hu S; Jurgens C J Infect Public Health; 2013 Dec; 6(6):423-30. PubMed ID: 23999333 [TBL] [Abstract][Full Text] [Related]
4. Clinical efficacy of oral linezolid compared with intravenous vancomycin for the treatment of methicillin-resistant Staphylococcus aureus-complicated skin and soft tissue infections: a retrospective, propensity score-matched, case-control analysis. Itani KM; Biswas P; Reisman A; Bhattacharyya H; Baruch AM Clin Ther; 2012 Aug; 34(8):1667-73.e1. PubMed ID: 22770644 [TBL] [Abstract][Full Text] [Related]
7. Methicillin-resistant Staphylococcus aureus in skin and soft tissue infections presenting to the Emergency Department of a Canadian Academic Health Care Center. Achiam CC; Fernandes CM; McLeod SL; Salvadori MI; John M; Seabrook JA; Theakston KD; Milburn S; Hussain Z Eur J Emerg Med; 2011 Feb; 18(1):2-8. PubMed ID: 20168235 [TBL] [Abstract][Full Text] [Related]
8. The benefit of empiric treatment for methicillin-resistant Staphylococcus aureus. Chuck EA; Frazee BW; Lambert L; McCabe R J Emerg Med; 2010 Jun; 38(5):567-71. PubMed ID: 18514468 [TBL] [Abstract][Full Text] [Related]
9. Community-onset methicillin-resistant Staphylococcus aureus skin and soft-tissue infections: impact of antimicrobial therapy on outcome. Ruhe JJ; Smith N; Bradsher RW; Menon A Clin Infect Dis; 2007 Mar; 44(6):777-84. PubMed ID: 17304447 [TBL] [Abstract][Full Text] [Related]
10. European perspective and update on the management of complicated skin and soft tissue infections due to methicillin-resistant Staphylococcus aureus after more than 10 years of experience with linezolid. Bassetti M; Baguneid M; Bouza E; Dryden M; Nathwani D; Wilcox M Clin Microbiol Infect; 2014 Apr; 20 Suppl 4():3-18. PubMed ID: 24580738 [TBL] [Abstract][Full Text] [Related]
11. Antibiotics for methicillin-resistant Staphylococcus aureus skin and soft tissue infections: the challenge of outpatient therapy. Pate AJ; Terribilini RG; Ghobadi F; Azhir A; Barber A; Pearson JM; Kalantari H; Hassen GW Am J Emerg Med; 2014 Feb; 32(2):135-8. PubMed ID: 24238483 [TBL] [Abstract][Full Text] [Related]
12. Is methicillin-resistant Staphylococcus aureus involved in community acquired skin and soft tissue infections? Experience from a tertiary care centre in Mumbai. Phakade RS; Nataraj G; Kuyare SS; Khopkar US; Mehta PR J Postgrad Med; 2012; 58(1):3-7. PubMed ID: 22387641 [TBL] [Abstract][Full Text] [Related]
14. Diagnostic and therapeutic evaluation of community-acquired methicillin-resistant Staphylococcus Aureus (MRSA) skin and soft tissue infections in the emergency department. Walraven CJ; Lingenfelter E; Rollo J; Madsen T; Alexander DP J Emerg Med; 2012 Apr; 42(4):392-9. PubMed ID: 21524884 [TBL] [Abstract][Full Text] [Related]
15. The impact of linezolid versus vancomycin on surgical interventions for complicated skin and skin structure infections caused by methicillin-resistant Staphylococcus aureus. Duane TM; Capitano B; Puzniak LA; Biswas P; Joshi M Surg Infect (Larchmt); 2013 Aug; 14(4):401-7. PubMed ID: 23859675 [TBL] [Abstract][Full Text] [Related]
16. Increasing incidence of methicillin-resistant Staphylococcus aureus skin and soft-tissue infections: reconsideration of empiric antimicrobial therapy. Awad SS; Elhabash SI; Lee L; Farrow B; Berger DH Am J Surg; 2007 Nov; 194(5):606-10. PubMed ID: 17936421 [TBL] [Abstract][Full Text] [Related]
17. Weight-based antibiotic dosing in a real-world European study of complicated skin and soft-tissue infections due to methicillin-resistant Staphylococcus aureus. Lawson W; Nathwani D; Eckmann C; Corman S; Stephens J; Solem C; Macahilig C; Li J; Baillon-Plot N; Charbonneau C; Haider S Clin Microbiol Infect; 2015 Sep; 21 Suppl 2():S40-6. PubMed ID: 26206621 [TBL] [Abstract][Full Text] [Related]
18. Empiric antimicrobial therapy for pediatric skin and soft-tissue infections in the era of methicillin-resistant Staphylococcus aureus. Elliott DJ; Zaoutis TE; Troxel AB; Loh A; Keren R Pediatrics; 2009 Jun; 123(6):e959-66. PubMed ID: 19470525 [TBL] [Abstract][Full Text] [Related]
19. Antibacterials as adjuncts to incision and drainage for adults with purulent methicillin-resistant Staphylococcus aureus (MRSA) skin infections. Forcade NA; Wiederhold NP; Ryan L; Talbert RL; Frei CR Drugs; 2012 Feb; 72(3):339-51. PubMed ID: 22316350 [TBL] [Abstract][Full Text] [Related]
20. Factors affecting the rise of treatment of resistant bacteria in skin and soft tissue infections in the United States: 1993-2012 Wetzel ME; Fleischer AB J Dermatolog Treat; 2017 Aug; 28(5):417-421. PubMed ID: 27813433 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]